ES2185937T3 - Procedimiento para realizar un examen sanguineo. - Google Patents

Procedimiento para realizar un examen sanguineo.

Info

Publication number
ES2185937T3
ES2185937T3 ES97923007T ES97923007T ES2185937T3 ES 2185937 T3 ES2185937 T3 ES 2185937T3 ES 97923007 T ES97923007 T ES 97923007T ES 97923007 T ES97923007 T ES 97923007T ES 2185937 T3 ES2185937 T3 ES 2185937T3
Authority
ES
Spain
Prior art keywords
blood
parameters
clinico
procedure
perform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97923007T
Other languages
English (en)
Inventor
Alexander W M Strasser
Karl Melber
Hans Dietrich Menssen
Eckard Thiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dynavax GmbH
Original Assignee
Rhein Biotech GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Biotech GmbH filed Critical Rhein Biotech GmbH
Application granted granted Critical
Publication of ES2185937T3 publication Critical patent/ES2185937T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE UN PROCEDIMIENTO PARA REALIZAR ANALISIS DE SANGRE. LA INVENCION SE BASA EN QUE LOS PARAMETROS CLINICO - QUIMICOS DE LA SANGRE SE PUEDEN DETERMINAR UTILIZANDO NO SOLAMENTE SUERO SANGUINEO SINO TAMBIEN PLASMA SANGUINEO. POR TANTO MUESTRAS SANGUINEAS RECIENTEMENTE TOMADAS SE MEZCLAN CON AL MENOS UN INHIBIDOR DE TROMBINA Y SE PUEDEN UTILIZAR PARA DETERMINAR PARAMETROS CLINICO - QUIMICOS Y PARAMETROS HEMATOLOGICOS. LOS PARAMETROS CLINICO - QUIMICOS SE PUEDEN DE ESTA MANERA DETERMINAR UTILIZANDO PLASMA SANGUINEO, NO SIENDO YA NECESARIO LA SEPARACION DE LOS COMPONENTES COAGULABLES.
ES97923007T 1996-05-21 1997-05-07 Procedimiento para realizar un examen sanguineo. Expired - Lifetime ES2185937T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19620443A DE19620443C2 (de) 1996-05-21 1996-05-21 Verfahren zum automatischen Durchführen von Bluttests

Publications (1)

Publication Number Publication Date
ES2185937T3 true ES2185937T3 (es) 2003-05-01

Family

ID=7794907

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97923007T Expired - Lifetime ES2185937T3 (es) 1996-05-21 1997-05-07 Procedimiento para realizar un examen sanguineo.

Country Status (10)

Country Link
US (1) US6521460B1 (es)
EP (1) EP0912891B1 (es)
JP (1) JP3523883B2 (es)
AT (1) ATE226322T1 (es)
AU (1) AU2893697A (es)
DE (2) DE19620443C2 (es)
DK (1) DK0912891T3 (es)
ES (1) ES2185937T3 (es)
PT (1) PT912891E (es)
WO (1) WO1997044661A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835721A1 (de) 1998-08-07 2000-02-10 Edi Experimentelle & Diagnosti Verfahren zur Bestimmung der Immunabwehr des Blutes sowie Testkit hierfür und Verwendung eines geeigneten Spritzenzylinders
US20060030758A1 (en) * 2004-08-09 2006-02-09 Francotyp-Postalia Ag & Co. Kg Mypersonallab
RU2419800C1 (ru) * 2010-03-18 2011-05-27 Федеральное Государственное Учреждение "Саратовский Научно-Исследовательский Институт Кардиологии Федерального Агентства По Высокотехнологичной Медицинской Помощи" Способ оценки риска повторных тромботических событий у больных острым коронарным синдромом
CN102778378A (zh) * 2012-08-07 2012-11-14 天津市百利康泰生物技术有限公司 一种含水蛭素的抗凝载玻片及其制备方法
EP2892496B1 (en) * 2012-09-06 2017-06-28 Theranos, Inc. Devices for bodily fluid sample collection
US9636062B2 (en) * 2012-09-06 2017-05-02 Theranos, Inc. Systems, devices, and methods for bodily fluid sample collection
US9427184B2 (en) * 2012-09-06 2016-08-30 Theranos, Inc. Systems, devices, and methods for bodily fluid sample collection
US10248765B1 (en) 2012-12-05 2019-04-02 Theranos Ip Company, Llc Systems, devices, and methods for bodily fluid sample collection, transport, and handling
US9386948B2 (en) 2012-12-05 2016-07-12 Theranos, Inc. Systems, devices, and methods for bodily fluid sample transport
EP2972184A4 (en) 2013-03-15 2016-11-30 Theranos Inc Methods and devices for sample collection and sample separation
CN113331832A (zh) 2014-03-12 2021-09-03 赛拉诺斯知识产权有限责任公司 用于体液样品收集的装置和方法
US10371606B2 (en) 2015-07-21 2019-08-06 Theraos IP Company, LLC Bodily fluid sample collection and transport
WO2017044888A1 (en) 2015-09-09 2017-03-16 Theranos, Inc. Methods and devices for sample collection and sample separation
US11857966B1 (en) 2017-03-15 2024-01-02 Labrador Diagnostics Llc Methods and devices for sample collection and sample separation
CN108152177B (zh) * 2017-12-11 2020-11-24 三诺生物传感股份有限公司 一种快速检测血细胞压积的方法
GB202018286D0 (en) * 2020-11-20 2021-01-06 Randox Laboratories Ltd Methods for use in preventative healthcare
CN113341163B (zh) * 2021-06-03 2024-01-19 上海市血液中心 一种-d-稀有血型筛选试剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372933A (en) 1988-10-03 1994-12-13 The Scripps Research Institute Polypeptides that mimic receptor-induced binding sites, and methods of using same
EP0442843B1 (de) * 1990-02-14 1998-09-09 Pentapharm A.G. Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
JP2965359B2 (ja) * 1991-01-07 1999-10-18 積水化学工業株式会社 血液検査用容器
DE4329969A1 (de) 1993-09-04 1995-03-09 Basf Ag Verfahren zur rekombinanten Herstellung von Proteinen in Hefe
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay

Also Published As

Publication number Publication date
DK0912891T3 (da) 2003-02-24
EP0912891A1 (de) 1999-05-06
DE59708506D1 (de) 2002-11-21
EP0912891B1 (de) 2002-10-16
US6521460B1 (en) 2003-02-18
PT912891E (pt) 2003-03-31
JP3523883B2 (ja) 2004-04-26
WO1997044661A1 (de) 1997-11-27
AU2893697A (en) 1997-12-09
JPH11511856A (ja) 1999-10-12
DE19620443C2 (de) 1998-09-17
ATE226322T1 (de) 2002-11-15
DE19620443A1 (de) 1997-11-27

Similar Documents

Publication Publication Date Title
ES2185937T3 (es) Procedimiento para realizar un examen sanguineo.
ES2088992T3 (es) Metodo para determinar los niveles de factores de coagulacion intrinsecos y extrinsecos y proteina c.
ATE304608T1 (de) Verfahren zur bestimmung des cholesteringehalts von high-density-lipoproteinen
ATE179800T1 (de) Vorrichtung und verfahren zur analyse von hdl- cholesterin in vollblut
ATE212674T1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
DE59914979D1 (de) Verfahren zur photometrischen auswertung von testelementen
DE3685937D1 (de) Testverfahren mit oberflaechengebundenem fibrinogen und loesliches markiertes fibrinogen.
BR9406944A (pt) Processos para a determinaçao imunológica para determinar de niveis de fibrinogênio no plasma IN VITRO,para a detecçao IN VITRO de polimeros de fibrina solúveis e polimeros de fibrina nao reticuladossoluveis em uma amostra de mamifero,e,em uma amostra de mamifero daquelas especies que formam um complexo com o anticorpo MH1 ,e kit para determinacaoda quantidade de polimeros de fibrina
ATE290688T1 (de) Test zur schnellen bestimmung von ischämischen zuständen und testsatz dafur
DE69719057D1 (de) Verfahren zur signalverstärkung
ES2098406T3 (es) Ensayo funcional y reactivo para la determinacion de fibrinogeno.
EP0790500A3 (en) Method of determining calibration curve and analysis method and apparatus using the same
DK314987A (da) Fremgangsmaade til specifik bestemmelse af serumfructosaminindhold samt hertil egnet reagensblanding
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
DK240787D0 (da) Analyseelement til bestemmelse af stoerkningsparametre
AU8600082A (en) Radioimmunoassay for fibrinopeptide a using a tripeptide thrombin inhibitor
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
DK0922229T3 (da) Fremgangsmåde til kontinuerlig eller diskontinuerlig automatisk analyse af pröver indeholdt i beholdere
DK157939C (da) Reagens til optisk bestemmelse af blodkoagulationsforholdet
AU2353188A (en) A diagnostic agent and a method for the determination of apolipoprotein b
CA2323442A1 (en) Method and apparatus for measuring proteins
EP0821239A3 (en) Method for measuring an amount of LDL-cholesterol
DK0788595T3 (da) Fremgangsmåde til undersögelse af immumkompetance
DK0906567T3 (da) Fremgangsmåde til fjernelse af hæmoglobininterferenser ved albuminbestemmelse
UA31304A (uk) Спосіб прогнозування тромботичних ускладнень в акушерській практиці